Media Assistance:
 Joni Westerhouse Executive Director for Medical Communications westerhousej@wustl.edu (314) 286-0120 |
| News Stories & Tip Sheets: |
|
Showing Stories 1 through 3 of 37. - Show More |
|
| Center's first director Bradley named head of proton beam therapy center (http://mednews.wustl.edu/news/page/normal/11868.html) June 5, 2008 -- Jeffrey Bradley, associate professor of radiation oncology, has been named the first director of the Kling Center for Proton Therapy, a facility for treating cancer patients with a new, highly precise form of radiation therapy. The center is scheduled to open in summer 2009 at the Siteman Cancer Center at the School of Medicine and Barnes-Jewish Hospital. |
| Better lung treatment Personalized therapy for asthma and COPD could soon be here (http://mednews.wustl.edu/news/page/normal/11806.html) May 18, 2008 -- Researchers at the School of Medicine have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and treatment of patients with chronic inflammatory lung disease. |
| Research network School of Medicine to lead international pediatric lung transplant research trials (http://mednews.wustl.edu/news/page/normal/11294.html) March 14, 2008 -- The School of Medicine has received a five-year, $3.9 million grant to lead an international research effort designed to improve outcomes for children undergoing lung transplants. Lung-transplant patients are subject to more frequent infections, organ rejection and other complications than patients with other transplanted organs. |
|
Showing Stories 1 through 3 of 37. - Show More |
|
| Faculty Experts: |
|
| Related News Clips: |
|
Showing 4 Clips. |
|
| Lung patients see a new era of transplants
The New York Times Sept. 25, 2006 -- Front page story -- A quiet revolution in the world of lung transplants is saving the lives of people who, just two years ago, would have died on the waiting list. Changes include who gets a lung transplant first -- people who would soon die without a transplant, but who had a good chance of surviving after one. Another major change is that more lungs from cadavers have become available. WUSTL transplant surgeon Alexander Patterson comments. WUSTL has one of the country's largest lung transplant programs. |
| Medicare says it will pay, but patients say 'no thanks'
New York Times and 2 others March 3, 2006 -- To test whether federal health spending actually helps patients, Medicare has been requiring more and more of the nation's retirees to participate in clinical trials to measure the effectiveness of a growing range of treatments, before agreeing to pay for them. After seeing the clinical trial's results and the risks involved, many patients and the doctors who refer them to surgeons seemed to lose their enthusiasm for the procedure. That first was a study of a risky but popular operation for patients with advanced emphysema, that was developed by then WUSTL surgeon Joel Cooper, who is now at U. Penn. Cooper published reports of his patients that were so promising that his medical center, Washington University, could hardly keep up with the demand. Cooper still stands by the lung volume reduction operation. |
| Treatment may aid asthma sufferers
Los Angeles Times and 61 others Feb. 2, 2006 -- A two-drug treatment may one day help restore healthy breathing in those with asthma and chronic bronchitis, according to a WUSTL study led by researcher Michael Holtzman. Holtzman and other researchers found that some cells lining the air passages of the lungs transform into another cell type in mice and humans with those disorders, leading to the overproduction of mucus in the airways. |
| Artificial heart can aid those on transplant waiting lists
USA Today.com, CBSnews.com and 21 others April 26, 2004 -- A type of temporary artificial heart to help near-death patients live long enough to receive a heart transplant has won the cautious backing of advisers to the Food and Drug Administration. The artificial heart is a complex and risky device that requires cutting out the bottom half of the human heart to implant. Side effects can include infection, bleeding and stroke. Patients implanted with the device are tethered to a washing machine-sized power generator until they can receive a donor heart. Still, the device "will fill a very important niche" for a small number of patients who have run out of other options, said Thomas Ferguson, professor emeritus of surgery at the School of Medicine. |
|
Related Information Related Groups:
|